Search PDMR transactions

Notifier
Name
Michael Wolff Jensen
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Michael Wolff Jensen
Position
MWJ Partners is associated with Michael Wolff Jensen; chairman of XSpray Pharma AB
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
XSprayPharma AB
LEI code
549300NGRQCNZ3X4L157
Details of transaction
Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price Currency code Transaction date Trading venue
XSpray Pharma AB, Transfer of shares due to earn-out agreement with Karolinske Development AB SE0009973563 Acquisition 4,997 Quantity 0.00 SEK 02/10/2017 FIRST NORTH SWEDEN
XSpray Pharma AB, Transfer of shares due to earn-out agreement with KCIF Co-Investment Fund Kommanditbolag SE0009973563 Acquisition 1,189 Quantity 0.00 SEK 02/10/2017 FIRST NORTH SWEDEN
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
XSpray Pharma AB, Transfer of shares due to earn-out agreement with Karolinske Development AB SE0009973563 Acquisition 02/10/2017 FIRST NORTH SWEDEN 4,997 (Quantity) 0.00 SEK
XSpray Pharma AB, Transfer of shares due to earn-out agreement with KCIF Co-Investment Fund Kommanditbolag SE0009973563 Acquisition 02/10/2017 FIRST NORTH SWEDEN 1,189 (Quantity) 0.00 SEK
<< Back